U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Sold by Victory Capital Management Inc.

Victory Capital Management Inc. reduced its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 9.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,189 shares of the company's stock after selling 3,319 shares during the period. Victory Capital Management Inc. owned approximately 0.21% of U.S. Physical Therapy worth $2,767,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in USPH. BNP Paribas Financial Markets raised its position in shares of U.S. Physical Therapy by 283.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company's stock valued at $1,425,000 after purchasing an additional 12,445 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of U.S. Physical Therapy by 57.1% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company's stock worth $223,000 after buying an additional 956 shares during the last quarter. State Street Corp raised its holdings in shares of U.S. Physical Therapy by 17.5% in the third quarter. State Street Corp now owns 667,868 shares of the company's stock worth $56,522,000 after buying an additional 99,244 shares during the last quarter. Stifel Financial Corp lifted its stake in shares of U.S. Physical Therapy by 12.1% during the third quarter. Stifel Financial Corp now owns 57,166 shares of the company's stock worth $4,838,000 after buying an additional 6,154 shares during the period. Finally, Quest Partners LLC grew its holdings in shares of U.S. Physical Therapy by 2,368.2% during the third quarter. Quest Partners LLC now owns 8,614 shares of the company's stock valued at $729,000 after buying an additional 8,265 shares during the last quarter.

Remove Ads

Insiders Place Their Bets

In other news, COO Graham D. Reeve sold 1,730 shares of the business's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $82.11, for a total transaction of $142,050.30. Following the transaction, the chief operating officer now directly owns 7,168 shares in the company, valued at $588,564.48. The trade was a 19.44 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.70% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

USPH has been the subject of a number of research analyst reports. William Blair restated a "market perform" rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. Bank of America raised U.S. Physical Therapy from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $100.00 to $115.00 in a report on Monday, December 16th. Citizens Jmp upgraded shares of U.S. Physical Therapy to a "strong-buy" rating in a report on Monday, December 16th. Barrington Research decreased their price objective on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a research note on Friday, February 28th. Finally, JMP Securities started coverage on shares of U.S. Physical Therapy in a report on Monday, December 16th. They issued an "outperform" rating and a $113.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, four have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, U.S. Physical Therapy currently has an average rating of "Moderate Buy" and a consensus price target of $109.00.

U.S. Physical Therapy Price Performance

Shares of U.S. Physical Therapy stock traded down $1.43 on Thursday, hitting $74.61. The company's stock had a trading volume of 43,981 shares, compared to its average volume of 98,579. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The company has a market capitalization of $1.13 billion, a price-to-earnings ratio of 79.43, a price-to-earnings-growth ratio of 3.54 and a beta of 1.51. The firm has a fifty day moving average price of $85.43 and a 200-day moving average price of $87.17. U.S. Physical Therapy, Inc. has a 1 year low of $74.51 and a 1 year high of $113.63.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing analysts' consensus estimates of $0.69 by ($0.04). The company had revenue of $180.45 million for the quarter, compared to analysts' expectations of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. As a group, sell-side analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 14th will be issued a $0.45 dividend. The ex-dividend date is Friday, March 14th. This represents a $1.80 dividend on an annualized basis and a yield of 2.41%. This is a positive change from U.S. Physical Therapy's previous quarterly dividend of $0.44. U.S. Physical Therapy's dividend payout ratio (DPR) is presently 97.83%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.